The Tales of 2 Indexes
The S&P 500 surged to a record high in Jan erasing the loss incurred from the fastest rate hike in recent history. The strong showing suggests the US economy remains strong and resilient despite the high-interest rate environment and geopolitical tensions.
Another index the CSI 300 made new lows since 2019 as China’s economy continued to stumble due to its real estate crisis. Falling real estate prices are starting to impact asset quality at banks where there is fear of contagion spreading to the financial sector.
Investors invested in the different countries obviously face different fortunes in terms of returns as each market takes its natural course.

The SRS Fund ended Jan down 3.86% as the Singapore market in general receded from its year-end high. Companies related to the China economy continued their downward trend and remained a drag to the SRS Fund performance.
Overall the SRS Fund underperform the STI Index by 2% for Jan. The first month of the year is non-eventful for Singapore-listed companies as the earnings season only kicks into full swing in February.
Keppel REIT and Mapletree PanAsia Commerical Trust reported inline results with DPU falling slightly due to higher interest and operational costs. I continue to see weakness in REITs despite lower interest rate expectations as the Sea Change from the ultra-low interest rate era will continue to impact REITs in the multi-year adjustment to normalise interest rates.
There were no buy or sell activities as I await more earnings reports to digest the quality of companies in the portfolio before deciding to make any changes.
Portfolio Segments

Segments in the SRS Fund remain stable with the finance sector making the bulk of it. I envision the reliance on the finance and property sector will continue to shrink in 2024 as more investments are made to divest into other sectors to make the fund more resilient.
Dividends

No dividend was collected in Jan but the total dividend expected for 2024 will likely continue to exceed the SRS Fund contribution limits as the snowball continues compounding.
SRS Fund Value

The SRS Fund retreated slightly to $366,121.81 in the absence of dividend and market weaknesses.
Cash Levels

The cash level remains low at 3.1% with the likelihood of rising due to dividends from portfolio companies in Q1


-

The SRS Fund Jun 2026
The month of Jun provided an important milestone in the Iran conflict. The agreement between the United States and Iran marked a significant step towards reducing geopolitical tension and reopening a clearer path for global energy flows
-

MyNest US Fund Jun 26
June was another remarkable month in the evolution of the global capitalism and the artificial intelligence investment cycle.
-

The SRS Fund May 2026
Korea, powered by the worldwide shortage and surge in memory demand, was hit directly by the AI wave, with its stock market more than doubling in a matter of 5 months. Taiwan, already the world’s most important advanced chip manufacturing hub has risen to become one of the largest stock market globally.
-

MyNest US Fund May 26
May has been an incredibly illuminating month for the MyNest US Fund. Looking across the broader landscape, the S&P 500 Index has continued its steady leg up, gaining +5.15% in the month of May alone to push its Year-to-Date (YTD) gain to +10.73%.
-

The SRS Fund Apr 2026
In my investment journey, there have been three occasions where I witnessed a company deliver a 10x return.
-

MyNest US Fund Apr 26
The market rebounded strongly in April as investors appeared to look past geopolitical uncertainty and renewed their focus on earnings, artificial intelligence, and the long-term growth prospects of quality businesses.

